Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients.
Sabbioni ME, Castiglione M, Hürny C, Siegrist HP, Bacchi M, Bernhard J, Thürlimann B, Bonnefoi H, Perey L, Goldhirsch A, Senn HJ. Sabbioni ME, et al. Among authors: castiglione m. Support Care Cancer. 1999 May;7(3):149-53. doi: 10.1007/s005200050245. Support Care Cancer. 1999. PMID: 10335933 Clinical Trial.
Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group.
Hürny C, Bernhard J, Coates A, Castiglione M, Peterson HF, Gelber RD, Rudenstam CM, Goldhirsch A, Senn HJ. Hürny C, et al. Among authors: castiglione m. Ann Oncol. 1994 Jan;5(1):65-74. doi: 10.1093/oxfordjournals.annonc.a058697. Ann Oncol. 1994. PMID: 8172795 Free article. Clinical Trial.
The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).
Hürny C, Bernhard J, Bacchi M, van Wegberg B, Tomamichel M, Spek U, Coates A, Castiglione M, Goldhirsch A, Senn HJ, et al. Hürny C, et al. Among authors: castiglione m. Support Care Cancer. 1993 Jul;1(4):200-8. doi: 10.1007/BF00366447. Support Care Cancer. 1993. PMID: 8193882
Present and future projects of the International Breast Cancer Study Group.
Goldhirsch A, Gelber RD, Castiglione M, Price KN, Rudenstam CM, Lindtner J, Collins J, Senn HJ, Brunner KW, Galligioni E, et al. Goldhirsch A, et al. Among authors: castiglione m. Cancer. 1994 Aug 1;74(3 Suppl):1139-49. doi: 10.1002/1097-0142(19940801)74:3+<1139::aid-cncr2820741524>3.0.co;2-k. Cancer. 1994. PMID: 8039150
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK).
Thürlimann B, Castiglione M, Hsu-Schmitz SF, Cavalli F, Bonnefoi H, Fey MF, Morant R, Löhnert T, Goldhirsch A. Thürlimann B, et al. Among authors: castiglione m. Eur J Cancer. 1997 Jun;33(7):1017-24. doi: 10.1016/s0959-8049(97)00105-6. Eur J Cancer. 1997. PMID: 9376181 Clinical Trial.
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.
Ribi K, Aldridge J, Phillips KA, Thompson A, Harvey V, Thürlimann B, Cardoso F, Pagani O, Coates AS, Goldhirsch A, Price KN, Gelber RD, Bernhard J; BIG 1-98 Collaborative Group; International Breast Cancer Study Group. Ribi K, et al. Br J Cancer. 2012 May 8;106(10):1618-25. doi: 10.1038/bjc.2012.156. Epub 2012 Apr 24. Br J Cancer. 2012. PMID: 22531635 Free PMC article. Clinical Trial.
189 results